Literature DB >> 29055350

Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.

Xiao-Feng He1, Long Zhang, Chun-Hua Zhang, Con-Ran Zhao, Heng Li, Ling-Fei Zhang, Guo-Feng Tian, Ming-Feng Guo, Zheng Dai, Fu-Ge Sui.   

Abstract

Previous studies suggested that oxidative stress is related to the onset and development of osteoporosis. Moreover, it was demonstrated that berberine has a protective effect against oxidative stress-induced injuries. In this study, we aimed to investigate the effect and mechanism of action of berberine on rats with induced osteoporosis. Sixty 8-week-old female Wistar rats were randomly divided into the following 6 groups: control saline-treated, osteoporosis saline-treated, 3 osteoporosis berberine-treated groups (Ber 5, 10, and 20 mg/kg/body weight, respectively), and osteoporosis alendronate-treated (ALD) group. Osteoporosis was induced by bilateral ovariectomy. All treatments were performed for 8 weeks. The bone mineral density (BMD), serum alkaline phosphatase (ALP), osteocalcin, calcium, phosphorus, superoxide dismutase (SOD), methylenedioxyamphetamine (MDA), and glutathione peroxidase (GSH-Px) level was determined in the rat femur tissue. The gene and protein expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) was analyzed by quantitative reverse transcription PCR and Western blot, respectively. The BMD, SOD and GSH⁃Px levels, and the expression of OPG were significantly lower in osteoporosis compared to control group (all p < 0.05). The serum levels of osteocalcin, ALP, and MDA, and the expression of RANKL were significantly higher in osteoporosis compared to control group (all p < 0.05). Berberine, especially the high doses of berberine, effectively increased SOD, GSH⁃Px, and OPG levels as well as decreased serum osteocalcin, ALP, MDA and RANKL levels in berberine-treated osteoporosis groups (all p < 0.05). To conclude, oxidative stress may promote the development of osteoporosis in rats through the RANK/RANKL/OPG pathway. The antioxidative effect of berberine reduces the development of osteoporosis in rats to some extent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055350      PMCID: PMC5708899          DOI: 10.17305/bjbms.2017.2596

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  21 in total

1.  [Effects of four components of Rhizoma Corydalis on anoxia and peroxidation injuries in neonatal cardiomyocytes].

Authors:  Peng Li; Junguo Ren; Changling Duan; Chengren Lin; Jianxun Liu
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2010-01

2.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.

Authors:  N Mody; F Parhami; T A Sarafian; L L Demer
Journal:  Free Radic Biol Med       Date:  2001-08-15       Impact factor: 7.376

3.  Alpha-Lipoic Acid Promotes Osteoblastic Formation in H2O2 -Treated MC3T3-E1 Cells and Prevents Bone Loss in Ovariectomized Rats.

Authors:  Chao Fu; Dong Xu; Chang-Yuan Wang; Yue Jin; Qi Liu; Qiang Meng; Ke-Xin Liu; Hui-Jun Sun; Mo-Zhen Liu
Journal:  J Cell Physiol       Date:  2015-09       Impact factor: 6.384

4.  Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.

Authors:  S-J Chen; W-C Liao; K-H Huang; C-L Lin; W-C Tsai; P-T Kung; K-H Chang; C-H Kao
Journal:  QJM       Date:  2015-01-21

Review 5.  Bone Degeneration, Inflammation and Secondary Complications of Arthritis: Potential Targets and their Natural Inhibitors.

Authors:  Mahadevappa Hemshekhar; Ram M Thushara; Somanathapura K Naveen Kumar; Manoj Paul; Mahalingam S Sundaram; Kempaiah Kemparaju; Kesturu S Girish
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

6.  Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.

Authors:  Jukka Vääräniemi; Jussi M Halleen; Katja Kaarlonen; Hannele Ylipahkala; Sari L Alatalo; Göran Andersson; Helena Kaija; Pirkko Vihko; H Kalervo Väänänen
Journal:  J Bone Miner Res       Date:  2004-06-14       Impact factor: 6.741

7.  The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient.

Authors:  B-J Kim; K-O Shin; H Kim; S H Ahn; S H Lee; C-H Seo; S-E Byun; J S Chang; J-M Koh; Y-M Lee
Journal:  J Endocrinol Invest       Date:  2015-07-29       Impact factor: 4.256

Review 8.  Action of RANKL and OPG for osteoclastogenesis.

Authors:  Yasuhiro Kobayashi; Nobuyuki Udagawa; Naoyuki Takahashi
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 9.  Immunology of Osteoporosis: A Mini-Review.

Authors:  Peter Pietschmann; Diana Mechtcheriakova; Anastasia Meshcheryakova; Ursula Föger-Samwald; Isabella Ellinger
Journal:  Gerontology       Date:  2015-06-17       Impact factor: 5.140

10.  Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level.

Authors:  Bo Zheng; Guangheng Li; William C W Chen; Bridget M Deasy; Jonathan B Pollett; Bin Sun; Lauren Drowley; Burhan Gharaibeh; Arvydas Usas; Bruno Péault; Johnny Huard
Journal:  J Orthop Res       Date:  2013-04-01       Impact factor: 3.494

View more
  10 in total

1.  Protective effects of berberine on senile osteoporosis in mice.

Authors:  Qing-Chang Chen; Yuan-Lin Pu; Jing Bi; Yan Zhang
Journal:  J Bone Miner Metab       Date:  2021-04-08       Impact factor: 2.626

2.  Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.

Authors:  Long Xiao; Mengdan Zhong; Yu Huang; Jie Zhu; Wenkai Tang; Danyong Li; Jiandong Shi; Aiqing Lu; Huilin Yang; Dechun Geng; Hong Li; Zhirong Wang
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

3.  Effects of berberine hydrochloride on methamphetamine-induced anxiety behaviors and relapse in rats.

Authors:  Leila Rezaeian; Hamid Kalalian-Moghaddam; Fahimeh Mohseni; Mehdi Khaksari; Raheleh Rafaiee
Journal:  Iran J Basic Med Sci       Date:  2020-11       Impact factor: 2.699

4.  Carboxymethyl chitosan reduces inflammation and promotes osteogenesis in a rabbit knee replacement model.

Authors:  Feng Liu; Hai-Yan Li; Zhen Wang; Hai-Ning Zhang; Ying-Zhen Wang; Hao Xu
Journal:  BMC Musculoskelet Disord       Date:  2020-11-24       Impact factor: 2.362

5.  Impact of Dehydroepiandrosterone (DHEA) on Bone Mineral Density and Bone Mineral Content in a Rat Model of Male Hypogonadism.

Authors:  Hussein F Sakr; Abdelaziz M Hussein; Elsayed A Eid; Ammar Boudaka; Lashin S Lashin
Journal:  Vet Sci       Date:  2020-11-23

6.  Estradiol and zinc-doped nano hydroxyapatite as therapeutic agents in the prevention of osteoporosis; oxidative stress status, inflammation, bone turnover, bone mineral density, and histological alterations in ovariectomized rats.

Authors:  Mona M Elghareeb; Gehad E Elshopakey; Tarek A Elkhooly; Basma Salama; Alaa Samy; Fuller W Bazer; Mohammed A Elmetwally; Mikhlid H Almutairi; Lotfi Aleya; Mohamed M Abdel-Daim; Shaymaa Rezk
Journal:  Front Physiol       Date:  2022-09-19       Impact factor: 4.755

Review 7.  Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis.

Authors:  Bingfeng Lin; Pingcui Xu; Juan Zheng; Xuehui Deng; Qitao Ye; Zhongping Huang; Nani Wang
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

8.  Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis.

Authors:  Mingxue Che; Weiquan Gong; Yao Zhao; Mingxi Liu
Journal:  Mol Med       Date:  2020-11-11       Impact factor: 6.354

9.  Berberine protects against diabetic retinopathy by inhibiting cell apoptosis via deactivation of the NF‑κB signaling pathway.

Authors:  Jiajia Zhai; Zeping Li; Huifeng Zhang; Louyan Ma; Zhengquan Ma; Yi Zhang; Jian Zou; Mo Li; Li Ma; Xin Wang; Xiaomiao Li
Journal:  Mol Med Rep       Date:  2020-09-14       Impact factor: 2.952

10.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.

Authors:  Lang Yang; Liuyi Fan; Kexin Wang; Yupeng Chen; Lan Liang; Xuemei Qin; Aiping Lu; Peng Cao; Bin Yu; Daogang Guan; Junxiang Peng
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.